The role of micro-RNA 223-3p as a potential biomarker of severity and predictor of outcomes in sepsis
The Egyptian Journal of Chest Diseases and Tuberculosis · 2026-04 · 75 (2) · 210-218
DOI: 10.4103/ecdt.ecdt_69_25 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Egyptian Journal of Chest Diseases and Tuberculosis, online erschienen am 08.04.2026. Verfasst von Mohamed S. Mousa und 4 weiteren Autor:innen. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Themen: Sepsis
Abstract (Originalsprache)
Background
Researchers discovered that microRNA 223-3p (miR-223-3p) was elevated in sepsis due to its dysregulation in infection, so the aim of our study was to identify the role of miR-223-3p expression as a potential biomarker and predictor of outcome in sepsis. Patients and methods Our study was a prospective observational cohort model consisting of 46 patients diagnosed as either sepsis or septic shock according to sepsis score 3, who were admitted to ICU. Four healthy individuals participated as a reference group for the expression of miR-223-3p. Serum samples were obtained for miR-223-3p gene expression by real-time PCR technology.
Results
The current study demonstrated that there was a higher mean value of miR-223-3p expression in sepsis cases (1.10±1.35) than in healthy persons (0.85±0.41). Pneumonia was the most common diagnosis in 24 (52.2%) cases. Klebsiella was the most predominant bacteria detected in this study 21 (45.7%) patients followed by 10 (21.7%) patients with Acinetobacter. There was a statistical significance difference between males and females, being higher in males ( P 0.046), also between smokers and nonsmokers, being higher in smokers than nonsmoker ( P 0.017). It was noticed that high expression of miRNA expression in Klebsiella and E coli infections. Correlation coefficient of miR-223-3p expression in relation to clinical and laboratory data showed the following: in spite of the expression being negatively correlated to body temperature, mean arterial blood pressure, white blood cells, platelet count, and liver functions but there was no statistically significant P value. Despite higher miRNA expression 223-3p in sepsis patients with disturbed consciousness, septic shock, nonsurvivors, and patients with positive fibrin degradation products, there was no statistically significant difference.
Conclusions
MiR-223-3p could be considered a promising biomarker for both marker of severity and predictor of outcomes in sepsis, providing perspectives to the exact molecular mechanisms and potential therapeutic targets. MiR-223-3pp showed higher expression with bacterial infection especially E-coli and klebsiella. These findings pay attention to the potentiality of miR-223-3p as both a diagnostic modality and tool of differentiation between sepsis etiologies and leading precision management.
Zitieren
APA
Mousa, M. S., Ahmed, S. H., Maksoud, F. A., Soliman, S. B., & Tantawy, A. A. (2026). The role of micro-RNA 223-3p as a potential biomarker of severity and predictor of outcomes in sepsis. The Egyptian Journal of Chest Diseases and Tuberculosis, 75(2), 210-218. https://doi.org/10.4103/ecdt.ecdt_69_25
Vancouver
Mousa MS, Ahmed SH, Maksoud FA, Soliman SB, Tantawy AA. The role of micro-RNA 223-3p as a potential biomarker of severity and predictor of outcomes in sepsis. The Egyptian Journal of Chest Diseases and Tuberculosis. 2026;75(2):210-218. doi:10.4103/ecdt.ecdt_69_25
BibTeX
@article{Mousa2026,
author = {Mousa, Mohamed S. and Ahmed, Salwa H. and Maksoud, Fatma A.W.A. and Soliman, Soliman B. and Tantawy, Ahmed A.},
title = {The role of micro-RNA 223-3p as a potential biomarker of severity and predictor of outcomes in sepsis},
journal = {The Egyptian Journal of Chest Diseases and Tuberculosis},
year = {2026},
volume = {75},
number = {2},
pages = {210--218},
doi = {10.4103/ecdt.ecdt_69_25}
}
EUVIMED